Hycult Biotech manufactures research reagents in the field of innate immunity.
The company focuses on products relating to antimicrobial peptides, complement, acute phase proteins, LPS and microbial toxins. The company also has a specific interest in inflammation and cell and tissue damage.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company contributes to research on inflammation and cell and tissue damage with knowledge in the development and production of assays, antibodies and proteins.
Source: LinkedIn company description · Retrieved October 13, 2026
The company offers research and diagnostic tools to assist in translating disease-understanding insights.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 27, 2026, September 29, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.